| Trial ID: | L7178 |
| Source ID: | NCT00982254
|
| Associated Drug: |
Oral Insulin
|
| Title: |
Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Oral insulin|DRUG: regular human insulin
|
| Outcome Measures: |
Primary: Glucose Infusion Rate (GIR), For each treatment continuously from 6 hours before dosing until 6 hours after dosing | Secondary: Plasma insulin concentration, For each treatment at regular times from 6 hours before dosing until 6 hours after dosing|Plasma C-Peptide, For each treatment at regular times from 6 hours before dosing until 6 hours after dosing|Adverse Events, For each treatment before and after end of clamp
|
| Sponsor/Collaborators: |
Sponsor: Profil Institut für Stoffwechselforschung GmbH | Collaborators: Emisphere Technologies, Inc.
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-10
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2009-09-23
|
| Locations: |
Profil Institut für Stoffwechselforschung GmbH, Neuss, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00982254
|
